← Browse by Condition
Medical Condition

treatment resistant depression trd

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT06668571 Phase 2
Recruiting

Intravenous Ketamine for Treatment-Resistant Depression

Enrollment
30 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06812923
Recruiting

TACS on High-inflammatory and Refractory Depression

Enrollment
52 pts
Location
China
Sponsor
Tianjin Anding Hospital
View Trial →
NCT07146503
Recruiting

Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression

Enrollment
100 pts
Location
Italy
Sponsor
Riccardo Guglielmo
View Trial →